Loading...
The Chronic Graft-vs.-Host Disease Failure-Free Survival (cGVHD-FFS) index
In clinical trials of chronic graft-versus-host disease (GVHD), the need to start a new systemic treatment is considered a treatment failure. A composite endpoint called “failure-free survival” (FFS) where events are initiation of a new systemic chronic GVHD treatment, recurrent malignancy, and deat...
Saved in:
| Published in: | Biol Blood Marrow Transplant |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6900444/ https://ncbi.nlm.nih.gov/pubmed/31394265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2019.07.040 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|